Treace Medical Concepts, Inc. (TMCI)
USD 7.83
(-5.89%)
USD 7.83
(-5.89%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -39 Million USD | -44.89% |
| 2022 | -34.84 Million USD | -101.18% |
| 2021 | -15.8 Million USD | -5055.17% |
| 2020 | 2.06 Million USD | 112.12% |
| 2019 | -2.63 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -17.05 Million USD | -381.61% |
| 2024 Q2 | -19.26 Million USD | -15.07% |
| 2024 Q3 | -15.13 Million USD | 33.12% |
| 2023 Q1 | -11.24 Million USD | -262.62% |
| 2023 FY | - USD | -44.89% |
| 2023 Q3 | -17.81 Million USD | -80.09% |
| 2023 Q2 | -9.89 Million USD | 12.01% |
| 2023 Q4 | -5.01 Million USD | 71.87% |
| 2022 Q2 | -11.38 Million USD | -46.85% |
| 2022 Q1 | -7.75 Million USD | -38.63% |
| 2022 FY | - USD | -101.18% |
| 2022 Q4 | -3.1 Million USD | 70.42% |
| 2022 Q3 | -10.48 Million USD | 7.89% |
| 2021 Q1 | -1.28 Million USD | -161.23% |
| 2021 Q4 | -5.59 Million USD | -6.17% |
| 2021 Q3 | -5.26 Million USD | -33.59% |
| 2021 Q2 | -3.94 Million USD | -207.01% |
| 2021 FY | - USD | -5055.17% |
| 2020 Q4 | 2.09 Million USD | 670.96% |
| 2020 Q3 | 272 Thousand USD | 123.61% |
| 2020 Q2 | -1.15 Million USD | -33.64% |
| 2020 Q1 | -862 Thousand USD | 0.0% |
| 2020 FY | - USD | 112.12% |
| 2019 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Acutus Medical, Inc. | -13.48 Million USD | -189.227% |
| Cerus Corporation | -26.53 Million USD | -47.0% |
| OrthoPediatrics Corp. | -8.38 Million USD | -365.434% |
| PetVivo Holdings, Inc. | -10.49 Million USD | -271.7% |
| Talis Biomedical Corporation | -66.04 Million USD | 40.937% |
| Vivos Therapeutics, Inc. | -16.67 Million USD | -133.931% |
| Inogen, Inc. | -45.67 Million USD | 14.604% |
| Spectral AI, Inc. | -12.26 Million USD | -218.121% |
| Nano-X Imaging Ltd. | -47.69 Million USD | 18.21% |
| CVRx, Inc. | -38.73 Million USD | -0.715% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -1005.669% |
| Helius Medical Technologies, Inc. | -12.1 Million USD | -222.194% |
| Orthofix Medical Inc. | -86.98 Million USD | 55.155% |
| Venus Concept Inc. | -26.11 Million USD | -49.382% |
| Accelerate Diagnostics, Inc. | -49.77 Million USD | 21.625% |
| Bioventus Inc. | -23.07 Million USD | -69.085% |
| BrainsWay Ltd. | -2.31 Million USD | -1587.927% |
| Envoy Medical, Inc. | -18.23 Million USD | -113.883% |
| electroCore, Inc. | -17.76 Million USD | -119.64% |
| IceCure Medical Ltd | -15.25 Million USD | -155.74% |
| Lucid Diagnostics Inc. | -49.75 Million USD | 21.594% |
| Monogram Orthopaedics, Inc. | -16.85 Million USD | -131.423% |
| MaxCyte, Inc. | -44.12 Million USD | 11.603% |
| NeuroOne Medical Technologies Corporation | -11.75 Million USD | -231.814% |
| Nexalin Technology, Inc. | -5.69 Million USD | -585.308% |
| PAVmed Inc | -75.74 Million USD | 48.499% |
| Rapid Micro Biosystems, Inc. | -53.75 Million USD | 27.438% |
| RxSight, Inc. | -41.03 Million USD | 4.944% |
| Sight Sciences, Inc. | -49.41 Million USD | 21.06% |
| SI-BONE, Inc. | -34.44 Million USD | -13.244% |
| TELA Bio, Inc. | -40.63 Million USD | 3.999% |
| TriSalus Life Sciences, Inc. | -58.29 Million USD | 33.089% |
| LivaNova PLC | 39.01 Million USD | 199.979% |
| 908 Devices Inc. | -34.02 Million USD | -14.645% |
| Alphatec Holdings, Inc. | -110.59 Million USD | 64.728% |
| Nemaura Medical Inc. | -7.28 Million USD | -435.305% |
| NeuroPace, Inc. | -22.83 Million USD | -70.833% |
| LENSAR, Inc. | -8.71 Million USD | -347.647% |
| Apyx Medical Corporation | -18.11 Million USD | -115.371% |
| Cutera, Inc. | -136.56 Million USD | 71.435% |
| STRATA Skin Sciences, Inc. | -3.38 Million USD | -1054.083% |
| BioSig Technologies, Inc. | -28.15 Million USD | -38.567% |
| Anika Therapeutics, Inc. | 2.51 Million USD | 1650.397% |
| ClearPoint Neuro, Inc. | -20.98 Million USD | -85.85% |
| Integra LifeSciences Holdings Corporation | 383.56 Million USD | 110.17% |
| Axonics, Inc. | 7.77 Million USD | 601.711% |
| Outset Medical, Inc. | -153.78 Million USD | 74.635% |
| IRIDEX Corporation | -7.44 Million USD | -423.738% |
| PROCEPT BioRobotics Corporation | -98.09 Million USD | 60.234% |
| IRadimed Corporation | 20.8 Million USD | 287.533% |
| Tivic Health Systems, Inc. | -8.06 Million USD | -383.85% |
| INVO Bioscience, Inc. | -6.88 Million USD | -466.975% |
| Telesis Bio, Inc. | -40.49 Million USD | 3.667% |
| Viemed Healthcare, Inc. | 36.67 Million USD | 206.355% |
| Varex Imaging Corporation | 67.2 Million USD | 158.048% |
| Quipt Home Medical Corp. | 44.07 Million USD | 188.512% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | -258.859% |
| Pulmonx Corporation | -55.09 Million USD | 29.195% |
| Dynatronics Corporation | -976 Thousand USD | -3896.689% |
| Modular Medical, Inc. | -17.1 Million USD | -128.077% |
| ReShape Lifesciences Inc. | -14.48 Million USD | -169.299% |
| Semler Scientific, Inc. | 23.58 Million USD | 265.365% |
| InMode Ltd. | 196.28 Million USD | 119.873% |
| Bruker Corporation | 599 Million USD | 106.512% |
| Cytosorbents Corporation | -28.81 Million USD | -35.394% |
| DexCom, Inc. | 916.7 Million USD | 104.255% |
| Align Technology, Inc. | 799.03 Million USD | 104.882% |
| Viveve Medical, Inc. | -20.61 Million USD | -89.203% |
| ZimVie Inc. | 91.07 Million USD | 142.832% |
| Movano Inc. | -29.12 Million USD | -33.933% |
| Cytek Biosciences, Inc. | -4.4 Million USD | -784.937% |
| Nexalin Technology, Inc. | -5.69 Million USD | -585.308% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -1005.669% |
| Tandem Diabetes Care, Inc. | -194.65 Million USD | 79.961% |
| Profound Medical Corp. | -27.12 Million USD | -43.816% |
| Insulet Corporation | 323.6 Million USD | 112.054% |
| enVVeno Medical Corporation | -25.01 Million USD | -55.92% |
| Surmodics, Inc. | 1.18 Million USD | 3383.502% |
| iCAD, Inc. | -6.56 Million USD | -494.181% |
| Nuwellis, Inc. | -16.35 Million USD | -138.494% |
| Biotricity, Inc. | -8.82 Million USD | -341.853% |
| iRhythm Technologies, Inc. | -96.86 Million USD | 59.728% |
| Aethlon Medical, Inc. | -11.84 Million USD | -229.206% |
| InspireMD, Inc. | -20.91 Million USD | -86.543% |
| PAVmed Inc. | -75.74 Million USD | 48.499% |
| BIOLASE, Inc. | -15.13 Million USD | -157.666% |
| Beyond Air, Inc. | -59.03 Million USD | 33.919% |
| FONAR Corporation | 28.25 Million USD | 238.074% |
| AxoGen, Inc. | -13.32 Million USD | -192.677% |
| Vivani Medical, Inc. | -26.6 Million USD | -46.603% |
| Tactile Systems Technology, Inc. | 24.54 Million USD | 258.95% |
| Inari Medical, Inc. | 7.11 Million USD | 648.404% |
| UFP Technologies, Inc. | 72.74 Million USD | 153.624% |
| QT Imaging Holdings, Inc. | -3.38 Million USD | -1052.111% |
| Heart Test Laboratories, Inc. | -6.15 Million USD | -533.659% |
| Tenon Medical, Inc. | -15.52 Million USD | -151.211% |
| Autonomix Medical, Inc. Common Stock | -15.26 Million USD | -155.522% |
| Co-Diagnostics, Inc. | -41.47 Million USD | 5.95% |
| AdaptHealth Corp. | -171.09 Million USD | 77.2% |
| Sintx Technologies, Inc. | -6.6 Million USD | -491.03% |
| NanoVibronix, Inc. | -3.43 Million USD | -1035.604% |
| Quanterix Corporation | -38.08 Million USD | -2.415% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | -258.859% |
| Sensus Healthcare, Inc. | 30 Thousand USD | 130126.667% |
| Pacific Biosciences of California, Inc. | -277.28 Million USD | 85.932% |
| TransMedics Group, Inc. | -7.6 Million USD | -413.061% |
| ReWalk Robotics Ltd. | -21.76 Million USD | -79.224% |
| NeuroMetrix, Inc. | -7.09 Million USD | -449.733% |
| Hyperfine, Inc. | -47.06 Million USD | 17.112% |
| Establishment Labs Holdings Inc. | -58.3 Million USD | 33.099% |
| Biomerica, Inc. | -5.99 Million USD | -550.893% |
| Bone Biologics Corporation | 479.57 Thousand USD | 8233.919% |
| AVITA Medical, Inc. | -39.56 Million USD | 1.415% |
| Bluejay Diagnostics, Inc. | -9.17 Million USD | -325.251% |
| Silk Road Medical, Inc | -45.08 Million USD | 13.469% |